Metabolite Identification of Myricetin in Rats Using HPLC Coupled with ESI-MS

Myricetin, a naturally occurring flavonol, shows multifarious pharmacological activities, e.g., antidiabetic, antioxidant, anti-inflammatory, antitumor, and liver protection effects. In order to obtain an understanding of the myricetin’s metabolism in vivo, a rapid and sensitive method by high-performance liquid chromatography coupled with electrospray-ionization mass spectrometry (HPLC-MS ⁿ ) techniques was employed to investigate the biotransformation in rats after oral administration of myricetin. Recognition and structural exposition of the metabolites were operated by comparing the changes in molecular mass (ΔM) and MS ⁿ spectra with the parent drug. As a result, the parent compound and seven metabolites were found in rat plasma, urine, and feces. In addition, besides 3,5-dihydroxyphenylacetic acid (M1) and 3,4,5-trihydroxyphenylacetic acid (M2), five other compounds were first discovered in the metabolite research of myricetin. These results indicated that, besides ring-fission, there were methylate (M3, M4, M5) and glucuronide (M6, M7) biotransformations of myricetin occurring in vivo.     

CZE-ESI-MS联用测定小肽混合物的研究

研究肽的分离行为、测定方法及测定条件对蛋白质组学研究具有重要意义 .毛细管电泳 ( CE)作为一种高效、快速的分离方法 ,样品用量少 ,已被广泛应用于生物领域中 ,尤其是小肽和蛋白质的分离分析 .质谱 ( MS)能够进行微量鉴定 ,并提供精确的分子量和结构信息 ,使其成为小肽和蛋白质检测和序列测定的强有力的支撑技术之一 [1～ 3] .其中 ,电喷雾 ( ESI)质谱作为一种软电离技术 ,易与常规的高分辨率分离方法如高效液相色谱、毛细管电泳等实现在线联用 ,具有分离效率高、检测灵敏度高和样品定性方便等特点 ,因而在小肽和蛋白质的测定中得到广…     

Identification of the New Metabolite of Nebivolol Using Liquid Chromatography Coupled with High-Resolution Mass Spectrometry and Chemometrics

In this study, the phase I hepatic metabolism pathway of a cardiovascular drug nebivolol was proposed on the basis of a human liver microsomes assay with the use of LC-HR-MS coupled with the chemometric method. Six biotransformation products were found with the assistance of chemometric analysis. Five of them were identified as the previously reported products of alicyclic hydroxylation and dihydroxylation, aromatic hydroxylation, as well as alicyclic oxidation of the parent compound. Moreover, one metabolite, not reported so far, was found to be a product of N-dealkylation of nebivolol—2-amino-1-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)ethan-1-ol. The novel metabolite was submitted to an in silico toxicity analysis to assess its biological properties. The applied computational methods indicated a significantly elevated risk of its mutagenic activity, compared to the parent molecule. Several metabolites of the nebivolol described in the literature were not detected in this study, indicating their non-hepatic origin.     

Chemical Profile of Danning Tablets by LC-DAD Coupled with ESI-MS

HPLC-DAD coupled to an electrospray tandem mass spectrometer (ESI-MS) has been developed to analysis the chemical profile of Danning tablets. Separation was performed on a ZORBAX Extend C₁₈ analytical column by gradient elution with acetonitrile and formate buffer (containing 12.6 mmol L⁻¹ formic acid, adjusted to pH 5.0 with ammonia) at a flow rate of 0.8 mL⁻¹ min. Twenty-three peaks were identifies as the major compounds in this preparation. Similarity measurements of the HPLC-UV chromatograms were investigated by a Similarity Evaluation System for Chromatographic Fingerprinting of Traditional Chinese Medicine (TCM) in the range of 0.84–0.99, and principal components analysis (PCA) on the quantitative analysis data was further performed to evaluate the variation among batches. The proposed method gives chemical profiles of multi-components in one run, and therefore can be readily utilized as a comprehensive quality control approach for TCM.     

Simultaneous Determination of Resibufogenin and Its Major Metabolite 3-epi-Resibufogenin in Rat Plasma by HPLC Coupled with Tandem Mass Spectrometry

A rapid, sensitive and specific method for the simultaneous quantification of resibufogenin (RBG) and 3-epi-resibufogenin (3-ERBG) in rat plasma was developed by using a liquid–liquid extraction procedure and liquid chromatography–electrospray ionization/tandem mass spectrometric (LC–ESI–MS/MS) analysis. The separation was performed by HPLC on a reversed phase C₁₈ HPLC column (150 × 2.1 mm, 3.5 μm) using a mobile phase of acetonitrilel-0.1% formic acid aqueous solution (45:55, v/v). The determination was performed by a triple-quadrupole mass spectrometer in the multiple reaction monitoring using positive mode of electrospray ionization (ESI). The calibration curves were both linear (R > 0.995) over the concentration range of 3.0–5,000 ng mL⁻¹, and the lower limits of quantification were 3.0 ng mL⁻¹ for both RBG and 3-ERBG. The intra-day and inter-day precisions (% RSD) were all less than 15%, and the accuracies (%RE) were within the range of ±15%. The mean recoveries of RBG, 3-ERBG and IS were over 82.7, 84.8 and 90.0% (n = 6), respectively. The method was proved to be rapid, sensitive and specific, and has been successfully applied to determine RBG and its major metabolite 3-ERBG in rat plasma after oral administration of RBG for pharmacokinetic study. Comparison of pharmacokinetic data with anti-tumor activities of RBG and ERBG suggested that 3-ERBG, as a major metabolite of RBG in rats, was perhaps also a bioactive form of RBG in vivo.

     

系列烷基甲基萘磺酸盐的高效液相色谱和电喷雾离子化质谱分析

采用反相离子对高效液相色谱(HPLC)和电喷雾离子化质谱(ESI-MS)对系列长链烷基甲基萘磺酸盐(AMNS),包括己基甲基萘磺酸盐、辛基甲基萘磺酸盐、癸基甲基萘磺酸盐、十二烷基甲基萘磺酸盐、十四烷基甲基萘磺酸盐进行分析,通过液相色谱分离条件的优化,找到了最佳分析条件.紫外检测波长230 nm,流动相为甲醇和水混合物,流速为0.8 mL/min,采用梯度洗脱方式进行分析.线性梯度:0～40 min时甲醇-水体积为60:40,在40～70min时,甲醇-水体积比为100:0.样品分离度高,分离效果较好.用面积归一化法得到了样品各组分的相对百分含量.HPLC和ESI-MS是快捷、有效和可靠的分析和表征AMNS的方法.     

HPLC/RI与HPLC/ESI-MS方法研究细菌D-97酶合成海藻糖的过程

 通过高效液相 /示差折光检测系统 (HPLC/RI)分析可获得细菌D 97利用糊精或淀粉水解物合成海藻糖的基本生物学信息 ,包括微生物培养碳源对细菌D 97胞内海藻糖合成酶系的影响以及该酶系利用不同种类或不同分子链长度的麦芽寡糖合成海藻糖的能力及作用过程。采用HPLC与RI及电喷雾电离质谱 (ESI MS)联用并结合其他生物学手段对由细菌D 97获得的纯酶组分 (酶A)作用产物进行定量和定性分析 ,从而基本明确了D 97胞内酶合成海藻糖的过程。     

苯丙胺类毒品及其衍生物的气相色谱-红外光谱分析

采用气相色谱一傅立叶变换红外光谱联用技术,建立了9种苯丙胺类毒品及其衍生物的分析鉴别方法.采用HP-1(30 m×0.32 mm,0.25 μm)毛细管柱,MCT红外检测器与氢火焰检测器同时检测,在程序升温条件下,以十七烷为内标物,研究已知对照品的色谱保留行为及其气态红外光谱图特征,建立相应的特征吸收峰数据库,作为鉴别分析的依据.色谱保留时间与红外特征吸收峰联合鉴别法极大地提高了鉴别的准确性.将发展的方法应用于可疑毒品物证中苯丙胺类及其衍生物毒品样品的鉴别,获得了理想的结果.本方法可用于涉毒案件毒品物证的检验,特别适用于混合毒品成分的检验.     

用C16-MCM-41介孔涂层新型固相微萃取-高效液相色谱分析环境水样中的痕量蒽

首次建立了1种用C16-MCM-41介孔复合材料作纤维涂层的固相微萃取(SPME)与高效液相色谱(HPLC)联用,测定环境水样中痕量葸的方法;对SPME的实验条件,如萃取和解吸时间、萃取温度、搅拌速度以及离子强度等进行了优化;方法的线性范围为0．018—71．2μg.L^-^1,检出限为5．9ng.L^-^1(S／N=3),相对标准偏差为0．033％(RSD,n=7);该法体现了SPME在样品前处理过程中的快速、灵敏、简单和无溶剂的特点。     

Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry

Sulfasalazine (SAS), an anti-inflammatory drug with potent cysteine/glutamate antiporter system xc-(SXC) inhibition has recently shown beneficial effects in brain-related diseases. Despite many reports related to central nervous system (CNS) effect of SAS, pharmacokinetics (PK) and metabolite identification studies in the brain for SAS were quite limited. The aim of this study was to investigate the pharmacokinetics and metabolite identification of SAS and their distributions in mouse brain. Using in vivo brain exposure studies (neuro PK), the PK parameters of SAS was calculated for plasma as well as brain following intravenous and oral administration at 10 mg/kg and 50 mg/kg in mouse, respectively. In addition, in vivo metabolite identification (MetID) studies of SAS in plasma and brain were also conducted. The concentration of SAS in brain was much lower than that in plasma and only 1.26% of SAS was detected in mouse brain when compared to the SAS concentration in plasma (brain to plasma ratio (%): 1.26). In the MetID study, sulfapyridine (SP), hydroxy-sulfapyridine (SP-OH), and N-acetyl sulfapyridine (Ac-SP) were identified in plasma, whereas only SP and Ac-SP were identified as significant metabolites in brain. As a conclusion, our results suggest that the metabolites of SAS such as SP and Ac-SP might be responsible for the pharmacological effect in brain, not the SAS itself.     

不相交主成分分析(PCA)和遗传算法(GA)用于差异表达基因的识别

建立了一种基于不相交主成分分析(Disjoint PCA)和遗传算法(GA)的特征变量选择方法, 并用于从基因表达谱(Gene expression profiles)数据中识别差异表达的基因. 在该方法中, 用不相交主成分分析评估基因组在区分两类不同样品时的区分能力; 用GA寻找区分能力最强的基因组; 所识别基因的偶然相关性用统计方法评估. 由于该方法考虑了基因间的协同作用更接近于基因的生物过程, 从而使所识别的基因具有更好的差异表达能力. 将该方法应用于肝细胞癌(HCC)样品的基因芯片数据分析, 结果表明, 所识别的基因具有较强的区分能力, 优于常用的基因芯片显著性分析(Significance analysis of microarrays, SAM)方法.     

Identification and comparative determination of senkyunolide A in traditional Chinese medicinal plants Ligusticum chuanxiong and Angelica sinensis by HPLC coupled with DAD and ESI-MS

Using the HPLC/DAD/ESI/MS method, the qualitative and quantitative analysis of senkyunolide A (SA) in the rhizomes of Ligusticum chuanxiong (Rhizoma chuanxiong; CX) and roots of Angelica sinensis (DG) was established. As a result, it was found that SA is a characteristic standard compound for the quality evaluation and chemical differentiation between CX and DG. Methanol was chosen in the preparation of standard solutions and extraction of samples based on the stability data. The identity of SA in CX and DG was unambiguously determined based on the quasimolecular ions in ESI-MS. A comprehensive validation of the method, including sensitivity, linearity, reproducibility and recovery, was conducted using the optimized chromatographic conditions. The linear calibration curve was acquired with R2>0.999 and limit of detection (S/N=3) was estimated to be 12.5 mug/g. The reproducibility was evaluated by repeated sample injection and replicated analysis of samples with the relative standard deviation (RSD) value found within 0.68%. The recovery rates of SA varied within the range of 96.91-101.50% with RSD less than 2.38%. In the present work, the contents of SA were quantified within 3.94-9.14 mg/g and 0.108-0.588 mg/g for 12 batches each of CX and DG. The results demonstrated that SA is a useful standard compound for the quality evaluation and chemical differentiation between CX and DG. The analytical procedure is precise and reproducible and thus suitable for the analysis of a large number of samples.     

Determination of Rhein Anthrone in Caecal Content of Rats Using Reversed Phase HPLC

Abstract

A sensitive spectrofluorimetric method is described to determine small quantities of rhein anthrone in complex biological systems as caecum content and faeces. The method is based on the stability and fluorescent properties of anthrone molecules in borax solution and combines the sensitivity of spectrofluorimetric methods with the resolution power of liquid chromatography.

After extraction of the faeces with a solution of sodium tetraborate and ascorbic acid in water and centrifugation, an aliquot of the supernatant is injected on a Sephadex-G25 precolumn. After rejection of the first fractions (fluorophors present in caecal content), rhein anthrone is collected on an RP-C18 column and eluted with an acetonitrile-borax buffer gradient. The anthrone is quantified using a fluorescence HPLC monitor.     

电喷雾质谱法和高效液相色谱法对dpq、ttd合成机理探讨

电喷雾质谱法和高效液相色谱法对dpq、ttd合成机理探讨;电喷雾质谱;高效液相色谱;反应机理;配体dpq;配体ttd     

MS／MS Study of Deoxydinucleotides Bound with Alkali—metal Ions Using ESI—MS

Positive ion ESI-MS has been used to examine the fragmentation pathways of the complex ions of deoxydinucleotides with H^ ,Na^ ,K^ by LCQ instrument.It had been found that the dissociation Varied markedly due to the differences of the base sequence.The alkali-metal ion binding site and the charcaterization of dissociation were directed by the size of metal ion,the sequesce of base and the steric hindrance.     

三维荧光二阶校正同时测定人体液中伊立替康及其代谢物7-乙基-10-羟基喜树碱的含量

提出了激发发射矩阵荧光光谱与化学计量学二阶校正方法相结合用于同时快速定量人体液(血浆和尿液)中的伊立替康(CPT11)和其主要代谢产物7-乙基-10-羟基喜树碱(SN38)的绿色、高灵敏分析策略. 尽管其分析物之间以及分析物和背景之间的光谱存在严重重叠现象, 采用基于交替归一加权残差(ANWE)算法的二阶校正方法进行解析仍能得到令人满意的定性定量分析结果. 当该体系的组分数选取为3时, 可以得到血浆和尿液中CPT11的平均回收率分别为(96.8±6.3)%和(101.7±1.1)%, SN38在血浆和尿液中的平均回收率分别为(100.4±4.9)%和(101.6±1.1)%. 另外, 通过品质因子, 如灵敏度(SEN)、选择性(SEL)、检测下限(LOD)和定量检测限(LOQ)评估了该方法的准确性. 实验结果表明, 该方法能以“数学分离”代替繁琐的“物理和化学分离”, 成功地解决实际复杂体系中内源干扰物质与分析物光谱重叠所引起的难分辨的问题, 可用于人体液中CPT11和SN38含量的直接快速定量测定.     

Rapid Purification and Identification of Osteopontin from Human Milk by HPLC Coupled to FT-ICR-MS

Milk as a key element for infant nutrition represents the only source of feeding for newborns and infants, breast-feeding milk normally contains several bioactive proteins or peptides useful for the development of the immune system that protects infants from diseases. Osteopontin(OPN) plays a distinct role during the processes of lactation. Some studies on OPN isolated and purified from the human milk via HPLC on SCX and C4 columns adopted biological mass spectrometry. After digesting the purified OPN sampl...     

Study on the determination of polyphenols in tobacco by HPLC coupled with ESI-MS after solid-phase extraction

A high-performance liquid chromatography method coupled with electrospray ionization-mass spectrometry for the determination of polyphenols in tobacco is studied. The polyphenols are extracted from a tobacco sample by being refluxed in a boiling water bath with 80% methanol and purified by solid-phase extraction with a C18 cartridge. The chlorogenic acid, rutin, scopoletin, caffeic acid, scopolin, and other polyphenols are satisfactorily separated on a Nova-Pak C18 chromatographic column (3.9 x 150 mm) with methanol and 0.05 mol/L potassium dihydrogen phosphate buffer solution gradient elution as mobile phase at a flow rate of 0.5 mL/min. Each of the polyphenols is monitored by photodiode array detector at its maximum wavelength: chlorogenic acid, 326.1 nm; rutin, 354.8 nm; scopoletin, 344.0 nm; caffeic acid, 323.7 nm; and scopolin, 365.2 nm. The limits of detection are: 100 ng/mL for chlorogenic acid, 125 ng/mL for rutin, 60 ng/mL for scopoletin, 50 ng/mL for caffeic acid, and 100 ng/mL for scopolin. The key polyphenols in tobacco are identified by comparing the retention time, the UV-spectrum, and the mass spectra with those of the standards. The recovery of tobacco polyphenols is 94-105%, and the relative standard deviations are 1.28-1.49%. This method is successfully applied to qualitatively and quantitatively analyze the polyphenols in tobacco with good results.     

Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS

The purpose of this study was to identify potential metabolic pathways and metabolites of OJT007, a methionine aminopeptidase 1 (MetAP1) inhibitor. OJT007 is a novel drug with potent antiproliferative effects against Leishmania Major. We conducted in vitro Phase I oxidation and Phase II glucuronidation assays on OJT007 using rat liver microsomes. Four unknown metabolites were initially identified using a UPLC-UV system from microsomal incubated samples. LC-MS/MS analysis was then used to identify the structural characteristics of these metabolites via precursor ion scan, neutral loss scan, and product ion scan. A glucuronide metabolite was further confirmed by β-glucuronidase hydrolysis. The kinetic parameters of OJT007 glucuronidation demonstrated that OJT007 undergoes rapid metabolism. These results demonstrate the liver’s microsomal ability to mediate three mono-oxidated metabolites and one mono-glucuronide metabolite. This suggests hepatic glucuronidation metabolism of OJT007 may be the cause of its poor oral bioavailability.